Notice of Lattice Biologics Ltd. Third Quarter 2017 Financial Results Conference Call
Financial results to be released after market on Tuesday, August 29, 2017
Lattice Biologics Ltd. (TSX -V: LBL) (OTCQB: LBLTF) (the “Company”) announced today it will release its third quarter
2017 financial results after market on Tuesday, August 29, 2017. Following this, Guy Cook, Chief Executive Officer, and Cheryl
Farmer, Chief Financial Officer, will host a conference call at 9:30 a.m. EDT on Wednesday, August 30, 2017, to review the results.
A question and answer session will follow the corporate update.
Subscribe to Lattice News Updates
Follow us on Twitter: @LatticeBio
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statement on Forward-Looking Information:
Certain information contained in this news release constitutes “forward-looking
statements” within the meaning of the “safe harbor” provisions of Canadian securities laws. All statements herein, other than
statements of historical fact, are to be considered forward looking. Generally, forward-looking information can be identified by
the use of forward-looking terminology such as “planned,” “potential,”“ future,” “expected,” “could,” “possible,”“
goal,” “intends,” “will” or similar expressions. Forward-looking statements in this news release
include, without limitation: information pertaining to the Company’s strategy, plans, or future financial performance, such as
statements with respect to the Transaction, and other statements that express
management’s expectations or estimates of future performance. Forward-looking statements involve known and unknown
risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of
Lattice to be materially different from those expressed or implied by such forward-looking statements.
Forward-looking statements are necessarily based upon a number of factors
and assumptions that, while considered reasonable by management as of the
date such statements are made, are inherently subject to significant business, economic and competitive uncertainties and
contingencies. The factors and assumptions that could prove to be incorrect, include, but are not limited to: that market prices
will be consistent with expectations, the continued availability of capital and financing, and that general economic, market and
business conditions will be consistent with expectations. The forward-looking statements are not guarantees of future performance.
We disclaim any obligation to update or revise any forward-looking statements, except as required by law. Readers are cautioned not
to put undue reliance on these forward-looking statements.
Lattice Biologics Ltd.
Cheryl Farmer, 480-563-0800
CFO
News@LatticeBiologics.com
www.LatticeBiologics.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170825005044/en/